Skip to main content
Erschienen in: Wiener klinische Wochenschrift 3-4/2015

01.02.2015 | original article

The possible impact of the German DRGs reimbursement system on end-of-life decision making in a surgical intensive care unit

verfasst von: Dr. med. Peter Stachura, MBA, Prof. Dr. Dr. h.c. Peter Oberender, Anika C. Bundscherer, MD, Priv.-Doz. Dr. med. habil. Christoph H. R. Wiese, MHBA

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 3-4/2015

Einloggen, um Zugang zu erhalten

Summary

Background

More than 70 % of critically ill patients die in intensive care units (ICUs) after treatment is reduced. End-of-life decision making in the ICU is a grey area that varies in practice, and there are potential economic consequences of over- and under-treatment. The aim of this study was to describe the end-of-life decisions of critically ill patients in a surgical ICU in Germany and to identify how financial incentives may influence decision making.

Methods

Data on the admission diagnosis, end-of-life decision making and cause of death were obtained for 69 critically ill patients who died in the ICU (Hospital of Bayreuth, Germany) in 2009. A cost-revenue analysis was conducted on the 46 patients who did not die within 3 days of ICU admission. Because we lacked real data on costs, our analysis was based on the average cost for each diagnosis-related group (DRG) from the Institute for the Hospital Remuneration System (InEK). Hospital revenues based on the DRG were considered. Subsequently, we compared the estimated financial impact of earlier and later decisions to withdraw or withhold futile therapy.

Results

In this study, we found that end-of-life decision making was poorly documented. Only 11 % of patients had a valid power of attorney and advanced directives, and therapy with presumed consent was performed in 43 % of all cases. From long-stay patients, therapy was withdrawn for 37 % of patients and withheld from 26 % of patients, and 37 % of the patients died receiving maximal therapy. Almost 72 % of DRG-related reimbursements were dependent on ventilation hours. The average total cost estimate (according to InEK) for the 46 long-stay patients was 1,201,000 €. The revenues without additional remuneration were 1,358,000 €, and the total estimated profit was approximately 157,000 €. Only 10 cases were assumed to be non-profitable. In cases where the decision to withdraw or withhold therapy could have occurred 3 days earlier, the estimated profit shrank to 72,000 € (46 % of estimated ICU profit). In situations where the decision to withdraw or withhold therapy from patients could have occurred 3 days later, the hypothetical profit rose to 217,000 € (138 % of estimated ICU profit).

Conclusion

There are still few patients with clear self-determination, and almost half of therapies are performed only according to presumed consent. The strong nonlinear dependence of DRG revenues on ventilation hours could influence ethical decision making of medical professionals. The decision-making process and appropriate therapy in the ICU setting need to be defined more clearly and better documented, focusing on the benefits to the patient while respecting patient consent.
Literatur
2.
Zurück zum Zitat Sprung CL. End-of-life practices in European intensive care units: the Ethicus Study. JAMA. 2003;290:790–7.CrossRefPubMed Sprung CL. End-of-life practices in European intensive care units: the Ethicus Study. JAMA. 2003;290:790–7.CrossRefPubMed
3.
Zurück zum Zitat Jean C, et al. Challenges in end-of-life care in the ICU. Intensive Care Med. 2004;30:770–84.CrossRef Jean C, et al. Challenges in end-of-life care in the ICU. Intensive Care Med. 2004;30:770–84.CrossRef
4.
Zurück zum Zitat Moerer O, Plock E, Mgbor U, Schmid A, Schneider H, Wischnewsky M, Burchardi H. A German national prevalence study on the cost of intensive care: an evaluation from 51 intensive care units. Crit Care. 2007;11:R69.CrossRefPubMedCentralPubMed Moerer O, Plock E, Mgbor U, Schmid A, Schneider H, Wischnewsky M, Burchardi H. A German national prevalence study on the cost of intensive care: an evaluation from 51 intensive care units. Crit Care. 2007;11:R69.CrossRefPubMedCentralPubMed
5.
Zurück zum Zitat Carr BG, Addyson DK, Kahn JM. Variation in critical care beds per capita in the United States: implications for pandemic and disaster planning. JAMA. 2010;303:1371–2.CrossRefPubMed Carr BG, Addyson DK, Kahn JM. Variation in critical care beds per capita in the United States: implications for pandemic and disaster planning. JAMA. 2010;303:1371–2.CrossRefPubMed
6.
Zurück zum Zitat Rhodes A, Ferdinande P, Flaatten H, Guidet B, Metnitz PG, Moreno RP. The variability of critical care bed numbers in Europe. Intensive Care Med. 2012;38:1647–53.CrossRefPubMed Rhodes A, Ferdinande P, Flaatten H, Guidet B, Metnitz PG, Moreno RP. The variability of critical care bed numbers in Europe. Intensive Care Med. 2012;38:1647–53.CrossRefPubMed
7.
Zurück zum Zitat Dorman T, Pauldine R. Economic stress and misaligned incentives in critical care medicine in the United States. Crit Care Med. 2007;35(Suppl):36.CrossRef Dorman T, Pauldine R. Economic stress and misaligned incentives in critical care medicine in the United States. Crit Care Med. 2007;35(Suppl):36.CrossRef
8.
Zurück zum Zitat Luce JM, White DB. The pressure to withhold or withdraw life-sustaining therapy from critically Ill patients in the United States. Am J Resp Crit Care Med. 2007;175:1104–8.CrossRefPubMedCentralPubMed Luce JM, White DB. The pressure to withhold or withdraw life-sustaining therapy from critically Ill patients in the United States. Am J Resp Crit Care Med. 2007;175:1104–8.CrossRefPubMedCentralPubMed
11.
Zurück zum Zitat World Medical Association. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Nurs Ethics. 2002;9:105–9.CrossRef World Medical Association. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Nurs Ethics. 2002;9:105–9.CrossRef
12.
Zurück zum Zitat Uil den CA, Lagrand WK, van der Ent M, Jewbali LS, Brugts JJ, Spronk PE, Simoons ML. The effects of intra-aortic balloon pump support on macrocirculation and tissue microcirculation in patients with cardiogenic shock. Cardiology. 2009;114:42–6.CrossRef Uil den CA, Lagrand WK, van der Ent M, Jewbali LS, Brugts JJ, Spronk PE, Simoons ML. The effects of intra-aortic balloon pump support on macrocirculation and tissue microcirculation in patients with cardiogenic shock. Cardiology. 2009;114:42–6.CrossRef
13.
Zurück zum Zitat Marasco SF, Lukas G, McDonald M, McMillan J, Ihle B. Review of ECMO (extra corporeal membrane oxygenation) support in critically Ill adult patients. Heart Lung Circ. 2008;17:41.CrossRef Marasco SF, Lukas G, McDonald M, McMillan J, Ihle B. Review of ECMO (extra corporeal membrane oxygenation) support in critically Ill adult patients. Heart Lung Circ. 2008;17:41.CrossRef
14.
Zurück zum Zitat Ronco C, Bellomo R, Ricci Z. Continuous renal replacement therapy in critically ill patients. Nephrol Dial Transpl. 2001;16(Suppl 5):67–72.CrossRef Ronco C, Bellomo R, Ricci Z. Continuous renal replacement therapy in critically ill patients. Nephrol Dial Transpl. 2001;16(Suppl 5):67–72.CrossRef
15.
Zurück zum Zitat White DB. Toward shared decision making at the end of life in intensive care units. Opportunities for improvement. Arch Intern Med. 2007;167:461.CrossRefPubMed White DB. Toward shared decision making at the end of life in intensive care units. Opportunities for improvement. Arch Intern Med. 2007;167:461.CrossRefPubMed
16.
Zurück zum Zitat Hennamari M, IImo K, Unto H. DRG-related prices applied in a public health care system- can Finland learn from Norway and Sweden? Health Policy. 2002;59:37–51.CrossRef Hennamari M, IImo K, Unto H. DRG-related prices applied in a public health care system- can Finland learn from Norway and Sweden? Health Policy. 2002;59:37–51.CrossRef
17.
Zurück zum Zitat Louis DZ, et al. Impact of a DRG-based hospital financing system on quality and outcomes of care in Italy. Health Serv Res. 1999;34:405–15.PubMedCentralPubMed Louis DZ, et al. Impact of a DRG-based hospital financing system on quality and outcomes of care in Italy. Health Serv Res. 1999;34:405–15.PubMedCentralPubMed
18.
Zurück zum Zitat Gunten CF von. Ensuring competency in end-of-life care: communication and relational skills. JAMA. 2000;284:3051–7.CrossRef Gunten CF von. Ensuring competency in end-of-life care: communication and relational skills. JAMA. 2000;284:3051–7.CrossRef
19.
Zurück zum Zitat Slomka J. The negotiation of death: clinical decision making at the end of life. Soc Sci Med. 1992;35:251–9.CrossRefPubMed Slomka J. The negotiation of death: clinical decision making at the end of life. Soc Sci Med. 1992;35:251–9.CrossRefPubMed
20.
Zurück zum Zitat McDermid RC, Bagshaw SM. Prolonging life and delaying death: the role of physicians in the context of limited intensive care resources. Philos Ethics Humanit Med. 2009;4:3.CrossRefPubMedCentralPubMed McDermid RC, Bagshaw SM. Prolonging life and delaying death: the role of physicians in the context of limited intensive care resources. Philos Ethics Humanit Med. 2009;4:3.CrossRefPubMedCentralPubMed
Metadaten
Titel
The possible impact of the German DRGs reimbursement system on end-of-life decision making in a surgical intensive care unit
verfasst von
Dr. med. Peter Stachura, MBA
Prof. Dr. Dr. h.c. Peter Oberender
Anika C. Bundscherer, MD
Priv.-Doz. Dr. med. habil. Christoph H. R. Wiese, MHBA
Publikationsdatum
01.02.2015
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 3-4/2015
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-014-0638-x

Weitere Artikel der Ausgabe 3-4/2015

Wiener klinische Wochenschrift 3-4/2015 Zur Ausgabe

mitteilungen der gesellschaft

Mitteilungen der Gesellschaft

MUW researcher of the month

Researcher of the month